Build your Science Company with Cube Labs

Call for Impactful Ventures in Healthcare

Call Opens: 22 January 2024
First Cut-Off Deadline for Review: 31 March 2024

Cube Labs is excited to announce our Call for Impactful Ventures for Cube Labs Venture Building, a unique opportunity for early stage life science and healthcare technology products and projects or startups at the pre-seed or seed-stage to commercialize their technology within Cube Labs’ supportive Venture Building environment.

 

Who we are looking for

Scientists

Technologists

Startup Founders

…addressing unmet needs in biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare technologies.

 

Objective

The primary goal of this Call for Impactful Ventures is to identify commercially promising projects in the life sciences domain and provide comprehensive support for their transformation into viable, market-ready ventures.

Cube Labs Program Benefits

150k-0.5M € in pre-seed investment funding

Access to office and laboratory facilities

Entrepreneurial and operational support

Project management and mentorship

Weekly feedback to guide progress

Access to both public and private funding

Eligibility Criteria and Requirements for Participation

We invite proposals from

  • Academic researchers with ground-breaking ideas.
  • Recently incorporated companies working on life science innovations.
  • Entrepreneurs (individuals or teams) with a strong vision for a life science venture.
 

Type and stage of development

Pre-seed or Early seed-stage

Venture building is designed for life science and healthcare technology products, projects and startups at the pre-seed or early seed-stage.

TRL 3 or PoC completed

We accept proposals from semi-built MedTech prototypes, preclinical stage projects and fully-fledged startups, with a minimum Technology Readiness Level = 3, or preclinical proof of concept completed.

Innovation

Your proposed product must be “innovative” and have the potential to serve an unmet need – incremental innovations or “me too” products are not the right fit.

IP Protection

Valid patent protection must be filed, or be available in the near future, for the technology, meaning in particular that there must not have been any publication or other public disclosure of the technology before patent protection has been sought*.

Commitment

Scientists/ Founders must be ready and committed to commercialization including dedicating a proportion of their own time to the venture.

Focus on Life Science

Your innovation addresses unmet needs in biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare technologies.

* Whilst all information gathered, reviewed, and documented within this process will be treated as confidential, your initial application should include only non-confidential information where possible, e.g. using code names/numbers for key molecules etc.

Application Process

To apply, please fill out the form via the link provided below. Selected projects will move through to detailed due diligence and assessment, where they will be invited to an interview with the Cube Labs team. Those not selected will be notified shortly after the deadline.

For any enquiry, please contact Cube Labs’ team at hello@cube-labs.com.

We look forward to receiving your proposals and joining forces to drive positive change in the healthcare innovation space!